Johannes Schmitt1, Bo Kong2, Grace L Guo2, Andreas Geier1,3, Bruno Stieger4, Oliver Tschopp5, Simon M Schultze5, Monika Rau1, Achim Weber6, Beat Müllhaupt3. 1. Division of Hepatology, Department of Medicine II, University Hospital Wuerzburg, DE-97080 Wuerzburg, Germany. 2. Department of Pharmacology and Toxicology Ernest Mario School of Pharmacy Rutgers University Piscataway, NJ 08854, USA. 3. Department of Gastroenterology & Hepatology, University Hospital Zurich (USZ), Zurich, Switzerland. 4. Department of Clinical Pharmacology and Toxicology, University Hospital Zurich (USZ), CH-8091 Zurich, Switzerland. 5. Division of Endocrinology, Diabetes, & Nutrition, University Hospital of Zurich, Zurich, Switzerland. 6. Department of Pathology, Institute of Surgical Pathology, University Hospital Zurich (USZ), Zurich, Switzerland.
Abstract
BACKGROUND & AIMS: There is a growing evidence that bile acids are involved in the regulation of triglyceride-, cholesterol-homoeostasis and fat absorption. In this study organ-specific Fxr knockout mice were used to further investigate the influence of farnesoid X receptor FXR in lipogenesis. METHODS: Liver- and intestine-specific Fxr knockout mice were fed a 1% cholesterol diet for 28 days. Histological examination of frozen tissue sections included Sudan III/H&E, BODIPY staining and liver X receptor (LXR) immunohistochemistry. Liver triglycerides, serum cholesterol, serum bile acids and nuclear LXR protein were measured. mRNA expression of several genes involved in bile acid-, cholesterol-homoeostasis and lipogenesis was quantified by real-time PCR. RESULTS: Hepatic FXR deficiency contributes to lipid accumulation under 1% cholesterol administration which is not observed in intestinal Fxr knockout mice. Strong lipid accumulation, characterized by larger vacuoles could be observed in hepatic Fxr knockout sections, while intestinal Fxr knockout mice show no histological difference to controls. In addition, these mice have the ability to maintain normal serum cholesterol and bile acid levels. Hepatic Fxr knockouts were characterized by elevated triglycerides and bile acid levels. Expression level of LXR was significantly elevated under control and 1% cholesterol diet in hepatic Fxr knockout mice and was followed by concomitant lipogenic target gene induction such as Fas and Scd-1. This protective FXR effect against hepatic lipid accumulation was independent of intestinal Fgf15 induction. CONCLUSION: These results show that the principal site of protective bile acid signalling against lipid accumulation is located in the liver since the absence of hepatic but not intestinal FXR contributes to lipid accumulation under cholesterol diet.
BACKGROUND & AIMS: There is a growing evidence that bile acids are involved in the regulation of triglyceride-, cholesterol-homoeostasis and fat absorption. In this study organ-specific Fxr knockout mice were used to further investigate the influence of farnesoid X receptorFXR in lipogenesis. METHODS: Liver- and intestine-specific Fxr knockout mice were fed a 1% cholesterol diet for 28 days. Histological examination of frozen tissue sections included Sudan III/H&E, BODIPY staining and liver X receptor (LXR) immunohistochemistry. Liver triglycerides, serum cholesterol, serum bile acids and nuclear LXR protein were measured. mRNA expression of several genes involved in bile acid-, cholesterol-homoeostasis and lipogenesis was quantified by real-time PCR. RESULTS:Hepatic FXR deficiency contributes to lipid accumulation under 1% cholesterol administration which is not observed in intestinal Fxr knockout mice. Strong lipid accumulation, characterized by larger vacuoles could be observed in hepatic Fxr knockout sections, while intestinal Fxr knockout mice show no histological difference to controls. In addition, these mice have the ability to maintain normal serum cholesterol and bile acid levels. Hepatic Fxr knockouts were characterized by elevated triglycerides and bile acid levels. Expression level of LXR was significantly elevated under control and 1% cholesterol diet in hepatic Fxr knockout mice and was followed by concomitant lipogenic target gene induction such as Fas and Scd-1. This protective FXR effect against hepatic lipid accumulation was independent of intestinal Fgf15 induction. CONCLUSION: These results show that the principal site of protective bile acid signalling against lipid accumulation is located in the liver since the absence of hepatic but not intestinal FXR contributes to lipid accumulation under cholesterol diet.
Authors: Johanna H M Stroeve; Gemma Brufau; Frans Stellaard; Frank J Gonzalez; Bart Staels; Folkert Kuipers Journal: Lab Invest Date: 2010-06-07 Impact factor: 5.662
Authors: Andreas Geier; Christoph G Dietrich; Tobias Grote; Ulrich Beuers; Thomas Prüfer; Peter Fraunberger; Siegfried Matern; Carsten Gartung; Alexander L Gerbes; Manfred Bilzer Journal: J Hepatol Date: 2005-07-01 Impact factor: 25.083
Authors: Lars P Bechmann; Peri Kocabayoglu; Jan-Peter Sowa; Svenja Sydor; Jan Best; Martin Schlattjan; Anja Beilfuss; Johannes Schmitt; Rebekka A Hannivoort; Alpaslan Kilicarslan; Christian Rust; Frieder Berr; Oliver Tschopp; Guido Gerken; Scott L Friedman; Andreas Geier; Ali Canbay Journal: Hepatology Date: 2013-04 Impact factor: 17.425
Authors: M Makishima; A Y Okamoto; J J Repa; H Tu; R M Learned; A Luk; M V Hull; K D Lustig; D J Mangelsdorf; B Shan Journal: Science Date: 1999-05-21 Impact factor: 47.728